SelectiVe Radical C-Glycosylation Reactions
J. Am. Chem. Soc., Vol. 123, No. 48, 2001 11881
described above for 9 (Table 2, entry 1) to give 17 (38 mg, 26% as a
white solid, R/â ratio ) 1:99) and 19 (83 mg, 61% as a white solid).
17: FAB-HRMS calcd for C29H26O7Na 509.1576 (MNa+), found
509.1604. 19: 1H NMR (CDCl3, 400 MHz) δ 8.13-7.36 (m, 15 H,
Ar), 5.82 (dd, 1 H, H-3, J ) 7.9, 7.9), 6.68 (ddd, 2 H, H-2, H-4, J )
4.7, 8.1, 8.1), 5.39 (dd, 2 H, H-1a, H-5a, J ) 4.7, 11.6), 4.58 (dd, 2 H,
H-1b, H-5b, J ) 8.1, 11.6); FAB-HRMS calcd for C26H22O7Na
469.1263 (MNa+), found 469.1263.
3-(2,3,4-Tri-O-benzoyl-D-xylopyranosyl)propionitrile (18) from
12 (Table 2, Entry 5). To a solution of 12 (228 mg, 301 µmol),
acrylonitrile (199 µL, 3.0 mmol), and Bu3SnH (162 µL, 600 µmol) in
benzene (3 mL) was added AIBN (10 mg, 61 µmol) at 80 °C, and the
mixture was heated at the same temperature. After disappearance of
the starting material on TLC, the mixture was evaporated, and the
residue was treated by the procedure described above for the allylation
of 12 (Table 2, entry 4). After purification by column chromatography
(SiO2, hexane/Et2O, 20:1), 18 was obtained (28 mg, 66% as an oil,
R/â ) 0:100): 1H NMR (CDCl3, 500 MHz) δ 8.10-7.20 (m, 15 H,
Ar), 5.88 (dd, 1 H, H-3, J ) 5.6, 10.8), 5.39 (ddd, 1 H, H-4, J ) 5.6,
10.8, 10.8), 5.34 (dd, 1 H, H-2, J ) 9.6, 9.6), 4.42 (dd, 1 H, H-5a,
J ) 5.6, 10.8), 3.76 (ddd, 1 H, H-1, J ) 2.9, 9.4, 9.4), 3.56 (dd,
1 H, H-5b, J ) 10.8, 10.8), 2.58 (m, 2 H, CH2CH2CN), 1.96 (m,
2 H, CH2CH2CN); FAB-HRMS calcd for C29H26NO7 500.1709 (MH+),
found 500.1689. Anal. Calcd for C29H25NO7‚0.3H2O: C, 68.98; H, 5.11;
N, 2.77. Found: C, 69.05; H, 5.11; N, 2.54.
Phenyl 2-Deoxy-3,4-di-O-acetyl-1-seleno-â-D-xylopyranoside (20).
To a solution of 2326 (2.82 g, 10.8 mmol) and PhSeH (2.39 mL, 21.6
mmol) in CH2Cl2 (72 mL) was added BF3‚OEt2 (2.33 mL, 18.4 mmol)
at 0 °C, and the mixture was stirred at room temperature for 30 min.
The mixture was partitioned between Et2O and aqueous saturated
NaHCO3, and the organic layer was washed with H2O and brine, dried
(Na2SO4), and evaporated. The resulting residue was purified by column
chromatography (SiO2, hexane/AcOEt, 5:1) to give 20 (3.36 g, 87%
as a white solid, R/â ratio ) ∼1:1 based on 1H NMR): 1H NMR
(CDCl3, 400 MHz) δ 7.58-7.27 (m, 5 H), 5.68 (dd, 0.55 H, J ) 4.4,
4.4), 5.55 (dd, 0.45 H, J ) 4.7, 4.7), 5.14-3.50 (m, 4 H), 2.65-2.00
(m, 8 H); FAB-HRMS calcd for C15H18O5SeNa 381.0217 (MNa+),
found 381.0220. Anal. Calcd for C15H18O5Se: C, 50.43; H, 5.08.
Found: C, 50.46; H, 5.16.
(MNa+), found 411.0702. Anal. Calcd for C17H24O5Se: C, 52.57; H,
6.21. Found: C, 52.72; H, 6.25.
Phenyl 3,4-Bis-O-triisopropylsilyl-2-deoxy-1-seleno-â-D-xylopyrano-
side (22). A mixture of 24 (369 mg, 1.35 mmol), TIPSOTf (1.09 mL,
4.06 mmol), and 2,6-lutidine (1.57 mL, 13.5 mmol) in CH2Cl2 (10 mL)
was stirred at room temperature for 30 min. After the addition of MeOH
(550 µL), the mixture was partitioned between AcOEt and aqueous 1
M HCl, and the organic layer was washed with H2O, aqueous saturated
NaHCO3, and brine, dried (Na2SO4), and evaporated. The resulting
residue was purified by column chromatography (SiO2, hexane/benzene,
15:1-10:1) to give 22 (736 mg, 93% as an oil, R/â ratio ) 1:1 based
1
on H NMR). The R/â mixture of 22 (736 mg) was further purified
by column chromatography (SiO2, hexane/benzene, 15:1) to give the
R-anomer (209 mg), the â-anomer (382 mg), and the R/â mixture
(145 mg). R-Anomer: 1H NMR (CDCl3, 400 MHz) δ 7.59-7.19
(m, 5 H, Ar), 5.81 (d, 1 H, H-1, J ) 5.5), 4.55 (d, 1 H, H-5a, J )
12.0), 4.01 (d, 1 H, H-3, J ) 2.8), 3.69 (br s, 1 H, H-4), 3.58 (d,
1 H, H-5b, J ) 12.0), 2.77 (ddd, 1 H, H-2a, J ) 2.8, 5.5, 14.0), 2.06
(d, 1 H, H-2b, J ) 14.0), 1.10 (m, 42 H, TIPS × 2); FAB-HRMS
calcd for C29H54O3SeSi2Na 609.2675 (MNa+), found 609.2682. Anal.
Calcd for C29H54O3SeSi2: C, 59.45; H, 9.29. Found: C, 59.17; H,
9.05. â-Anomer: 1H NMR (CDCl3, 400 MHz) δ 7.62-7.25 (m,
5 H, Ar), 5.46 (dd, 1 H, H-1, J ) 2.2, 10.5), 3.99 (br s, 1 H, H-3), 3.98
(dd, 1 H, H-5a, J ) 1.0, 11.8), 3.83 (dd, 1 H, H-5b, J ) 2.4, 11.8),
3.61 (br s, 1 H, H-4), 2.38 (ddd, 1 H, H-2a, J ) 2.5, 10.5, 13.3), 1.90
(m, 1 H, H-2b), 1.05 (m, 42 H, TIPS × 2); FAB-HRMS calcd for
C29H54O3SeSi2Na 609.2675 (MNa+), found 609.2645. Anal. Calcd for
C29H54O3SeSi2‚0.3H2O: C, 58.91; H, 9.31. Found: C, 58.98; H, 8.95.
1-[2H]-1,5-Anhydro-2-deoxy-3,4-di-O-acetyl-D-xylitol (25) from
20 (Table 3, Entry 1). After treatment of 20 (50 mg, 140 µmol)
according to the procedure described for the deuteration of 8 (Table 1,
entry 1), 25 (28 mg, 97% as an oil, R/â ratio ) 84:16) was obtained:
1H NMR (CDCl3, 500 MHz) δ 5.00 (ddd, 1 H, H-3, J ) 4.6, 8.1, 8.1),
4.83 (ddd, 1 H, H-4, J ) 4.2, 7.5, 7.5), 3.98 (dd, 1 H, H-5a, J ) 4.2,
11.7), 3.87 (m, 0.84 H, H-1â), 3.54 (m, 0.16 H, H-1R), 3.39 (dd, 1 H,
H-5b, J ) 7.5, 11.7), 2.12 (m, 1 H, H-2a), 2.07 (m, 6 H, Ac × 2), 1.73
(m, 1 H, H-2b): 2H NMR (CHCl3, 400 MHz) δ 3.33 (â-anomer), 3.00
(R-anomer); ESI-HRMS calcd for C9H13DO5Na 226.0802 (MNa+),
found 226.0806.
Compound 25 from 21 (Table 3, Entry 2). After treatment of 21
(54 mg, 104 µmol) according to the procedure described for the
deuteration of 9 (Table 1, entry 2), 25 (18 mg, 61% as an oil, R/â ratio
) 99:1) was obtained: 2H NMR (CHCl3, 400 MHz) δ 3.33 (â-anomer),
3.00 (R-anomer); ESI-HRMS calcd for C9H13DO5Na 226.0802 (MNa+),
found 226.0806.
Compound 25 from 22 (Table 3, Entry 4). After treatment of 22
(82 mg, 140 µmol) according to the procedure described for the
deuteration of 12 (Table 1, entry 5), 25 (20 mg, 71% as an oil,
R/â ratio ) 72:28) was obtained: 2H NMR (CHCl3, 400 MHz) δ 3.33
(â-anomer), 3.00 (R-anomer); ESI-HRMS calcd for C9H13DO5Na
226.0802 (MNa+), found 226.0808.
Phenyl 2-Deoxy-1-seleno-â-D-xylopyranoside (24). A mixture
of 20 (1.98 g, 5.54 mmol) and NaOMe (28% in MeOH, 100 µL) in
THF/MeOH (5 mL/5 mL) was stirred at room temperature for 2 h
and neutralized with Diaion PK 212 resin (H+ form). The resin was
filtered off, and the filtrate was evaporated and dried in vacuo at
room temperature for 1 h to give 24 (1.51 g, 99% as a white solid, R/â
ratio ) 1:1): 1H NMR (CDCl3, 400 MHz) δ 7.55 (m, 2 H), 7.26 (m,
3 H), 5.84 (dd, 0.54 H, J ) 2.0, 5.1), 5.19 (dd, 0.46 H, J ) 2.8, 8.7),
4.23-3.25 (m, 4 H), 2.51-1.80 (m, 4 H); FAB-HRMS calcd for
C11H14O3SeNa 297.0006 (MNa+), found 297.0028. Anal. Calcd for
C11H14O3Se: C, 48.36; H, 5.17. Found: C, 48.26; H, 5.05.
Phenyl 2-Deoxy-3,4-O-[(2S,3S)-2,3-dimethoxybutan-2,3-diyl]-1-
seleno-â-D-xylopyranoside (21). Compound 21 (1.68 g, 89% as a white
solid, R/â ratio ) 1:1 based on 1H NMR) was obtained from 24 (1.34
g, 4.9 mmol) as described for the synthesis of 10, after purification by
column chromatography (SiO2, hexane/AcOEt, 20:1). The R/â mixture
of 24 (600 mg) was further purified by silica gel chromatography (SiO2,
hexane/AcOEt, 25:1) to give the R-anomer (223 mg), the â-anomer
(111 mg), and the R/â mixture (252 mg). R-Anomer: 1H NMR (CDCl3,
400 MHz) δ 7.57-7.25 (m, 5 H, Ar), 5.93 (d, 1 H, H-1, J ) 4.7),
4.10-3.65 (m, 4 H, H-3, H-4, H-5a, H-5b), 3.31 (s, 3 H, OMe), 3.28
(s, 3 H, OMe), 2.30 (ddd, 1 H, H-2b, J ) 1.7, 5.0, 11.7), 2.23 (ddd, 1
H, H-2a, J ) 5.3, 11.7, 11.7), 1.32 (s, 3 H, Me), 1.31 (s, 3 H, Me);
FAB-HRMS calcd for C17H24O5SeNa 411.0687 (MNa+), found 411.0681.
Anal. Calcd for C17H24O5Se‚0.1H2O: C, 52.47; H, 6.27. Found: C,
52.24; H, 6.16. â-Anomer: 1H NMR (CDCl3, 400 MHz) δ 7.62-7.30
(m, 5 H, Ar), 5.00 (dd, 1 H, H-1, J ) 2.1, 11.7), 4.00 (dd, 1 H, H-5a,
J ) 5.0, 10.6), 3.74 (ddd, 1 H, H-3, J ) 4.4, 9.7, 9.7), 3.66 (ddd, 1 H,
H-4, J ) 5.0, 9.8, 9.8), 3.36 (dd, 1 H, H-5b, J ) 10.6, 10.6), 3.25 (s,
3 H, OMe), 3.07 (s, 3 H, OMe), 2.23 (ddd, 1 H, H-2a, J ) 2.1, 4.4,
11.7), 1.89 (ddd, 1 H, H-2b, J ) 11.7, 11.7, 11.7), 1.29 (s, 3 H, Me),
1.28 (s, 3 H, Me); FAB-HRMS calcd for C17H24O5SeNa 411.0687
3-(2-Deoxy-2,3,4-tri-O-benzoyl-D-xylopyranosyl)propene (26) from
21 (Table 3, Entry 3). After treatment of 21 (117 mg, 301 µmol)
according to the procedure described for the allylation of 9 (Table 2,
entry 1), 26 (61 mg, 74% as an oil, R/â ratio ) 98:2) was obtained:
1H NMR (CDCl3, 500 MHz) δ for the R-anomer 8.15-7.29 (m, 10 H,
Ar), 5.86 (m, 1 H, CHdCH2), 5.42 (d, 1 H, H-3, J ) 1.5), 5.11 (m, 3
H, H-4, CHdCH2), 4.19 (d, 1 H, H-5a, J ) 13.2), 4.09 (dd, 1 H, H-5b,
J ) 1.3, 13.2), 3.86 (m, 1 H, H-1), 2.37 (m, 2 H, CH2CHdCH2), 2.04
(m, 2 H, H-2a, H-2b); 1H NMR (CDCl3, 500 MHz) δ for the â-anomer
8.15-7.29 (m, 10 H, Ar), 5.86 (m, 1 H, CHdCH2), 5.41 (ddd, 1 H,
H-3, J ) 5.3, 10.7, 10.7), 5.33 (ddd, 1 H, H-4, J ) 5.4, 10.7, 10.7),
5.11 (m, 2 H, CHdCH2), 4.35 (dd, 1 H, H-5a, J ) 5.3, 10.7), 3.63 (m,
1 H, H-1), 3.44 (dd, 1 H, H-5b, J ) 10.7, 10.7), 2.37 (m, 2 H, CH2-
CHdCH2), 1.71 (m, 2 H, H-2); FAB-HRMS calcd for C22H22O5Na
389.1365 (MNa+), found 389.1369. Anal. Calcd for C22H22O5: C, 72.12;
H, 6.05. Found: C, 72.03; H, 6.22.
Compound 26 and 1,5-Anhydro-2-deoxy-3,4-di-O-benzoyl-D-
xylitol (28) from 22 (Table 3, Entry 5). After treatment of 22 (176
mg, 301 µmol) according to the procedure described for the allylation
of 12 (Table 2, entry 4), 26 (36 mg, 34% as an oil, R/â ratio ) 46:54)